Switching ECT Technique: New Editorial in Acta Psychiatrica Scandinavica

Out on PubMed from ECT experts Pascal Sienaert and Declan McLoughlin, is this editorial:

Changing tactics: Does switching improve electroconvulsive therapy outcomes?

Sienaert P, McLoughlin DM.Acta Psychiatr Scand. 2023 Apr;147(4):319-321. doi: 10.1111/acps.13540.PMID: 36945826

The editorial is here.

And here:

This is a thoughtful and important editorial. Like many such pieces, it asks more questions than it answers. We certainly are eager to have the results of the RUL-to-BL switching trial that is described in reference #13, to answer some of them.
But let's back up a bit and ask 30,000 ft questions. Do we really believe that RUL ECT is as "strong," "effective," "powerful," "non-inferior," "as good as" BL ECT? One interpretation of some of the evidence base suggests so, but this is discordant with decades of clinical experience and the widespread practice of switching to BL electrode placement for non-, or slow, response. And what about clinical severity/urgency? My 2001 editorial (referenced in this editorial) was widely misinterpreted as advocating one type of treatment (including identical anesthesia doses!) for all. In fact, I advocated one kind of treatment (with emphasis on efficacy, not tolerability issues) for most, not all, patients; I have always argued that decisions about ECT technique should be based on severity/urgency of illness, with sicker patients preferentially starting with BL electrode placement. And by "sicker" I mean probably about 30-40% of patients seen in a typical ECT clinic.
Even if "most" patients should get RUL ECT, certainly "some", the most urgently ill, still should still get BL ECT, no?


Comments

  1. ECT BloggerMarch 30, 2023 at 9:13 AM

    The below comment is from Dr. Max Fink:

    RUL vs BT assessments were reported in 1957, 1973, 1990s (by CORE) etc, etc. BT is more effective than RUL, averaging 85-90% compared to 65%. Instead of such repeated studies using electricity stimuli, flurothyl inhalant stimulation offers equal EEG, seizure duration, lower cognitive effects to BT. Flurothyl inhalant seizures warrant trials rather than repeated BT vs RUL over 70 years. Flurothyl inductions warrant retrial.

    Max Fink, M.D.

    ReplyDelete

Post a Comment

Popular posts from this blog

ECT plus Antidepressants: a Review

Out on PubMed, from researchers in Rotterdam, The Netherlands, is this review: Influence of an adjuvant antidepressant on the efficacy of  electroconvulsive  therapy: A systematic review and meta-analysis. Pluijms EM, Kamperman AM, Hoogendijk WJ, Birkenhäger TK, van den Broek WW. Aust N Z J Psychiatry. 2020 Sep 8:4867420952543. doi: 10.1177/0004867420952543. Online ahead of print. PMID:  32900217 Here is the "Conclusion" section from the text: Our results suggest that an adjuvant antidepressant enhances the efficacy of ECT in patients with major depression. Although the included studies had some methodological limitations, effect sizes were consistently small to moderate. We speculate that modern-day controlled trials using adequately dosed TCAs and MAOIs will most likely result in larger effect sizes. From a clinical point of view, we prefer an adjuvant TCA to an adjuvant MAOI, since TCAs are generally safe to use with ECT ( American Psychiatric Association, 2001 ; ...
Read more

Clinical Phenotype of Behavioral-Variant Frontotemporal Dementia Reversed by ECT: A Case Report

Image
Out on PubMed, from authors in Germany, is this case report and literature review: Clinical Phenotype of Behavioral-Variant Frontotemporal Dementia Reversed by  ECT : A Case Report. Breitling B, Bartels C, Lange C, Bouter C, Falk HS, Wiltfang J, Zilles-Wegner D, Besse M. Neuropsychobiology. 2024 Dec 2:1-12. doi: 10.1159/000541668. Online ahead of print. PMID:  39622206 The abstract is copied below: Introduction: Diagnosis of frontotemporal dementia (FTD) remains difficult even in the presence of core clinical and imaging features. Furthermore, disease-modifying treatments are lacking. Case presentation: Here, we report a case of a patient with clinical and imaging features of FTD. Electroconvulsive therapy (ECT) was used to target affective and catatonic symptoms. After ECT, the patient showed improvements not only in affective symptoms but also in cognitive domains, leading to a marked improvement in the patient's level of functioning. Conclusion: Against the background of di...
Read more

Early Use of the Name "ECT"- Sacklers in 1949

Image
 "Classics in ECT" brings you this study from Creedmore State Hospital in 1949: Nonconvulsive biochemotherapy with histamine and electric convulsive therapy; a comparative study on hospitalized psychotics with a control  ECT  series. SACKLER AM, SACKLER MD, SACKLER RR. J Nerv Ment Dis. 1949 Sep;110(3):185-97. doi: 10.1097/00005053-194911030-00001. PMID:  18138865 The pdf is here . I originally choose this article as the earliest in PubMed to use the name, "ECT," although it also uses "electric [sic] convulsive therapy."  The very first PubMed "ECT" citation is from 1947, but it is written "E.C.T." and also reports a complication, so we prefer this one. Nomenclature aside, this turns out to be an interesting read, with what would now be considered a somewhat bizarre study comparing histamine therapy with ECT. Among the interesting details are the inclusion of a couple of patients with postpartum psychosis and the observation that longer ...
Read more